| 711638 |
INDIAN HEART JOURNAL : OFFICIAL PUBLICATION OF THE CARDIOLOGICAL SOCIETY OF INDIA |
Percutaneous edge-to-edge Mitral valve repair for symptomatic high surgical risk patients with significant mitral regurgitation – Short term and one year follow up results from a single center in India |
2021-07-01 |
10.1016/j.ihj.2021.05.003 |
Satish Sai, Kar Saibal, Indani Ashish, Subban Vijayakumar, Arumugam Ganapathy, Senthil Hemalatha, Kethavath Hema, Kalarickal Mathew Samuel, Chandrasekaran Krishnaswamy |
| 711637 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Qing-Luo-Yin Alleviated Monocytes/Macrophages-Mediated Inflammation in Rats with Adjuvant-Induced Arthritis by Disrupting Their Interaction with (Pre)-Adipocytes Through PPAR-γ Signaling |
2021-07-01 |
10.2147/dddt.s320599 |
Wang Rui, Li Dan-Feng, Hu Yi-Fang, Liao Qiang, Jiang Tian-Tian, Olatunji Opeyemi Joshua, Yang Kui, Zuo Jian |
| 711636 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Effect of Berberine on Hyperuricemia and Kidney Injury: A Network Pharmacology Analysis and Experimental Validation in a Mouse Model |
2021-07-01 |
10.2147/dddt.s317776 |
Li Qiaoping, Huang Ziwei, Liu Defu, Zheng Jingna, Xie Jianhui, Chen Jiannan, Zeng Huifang, Su Ziren, Li Yucui |
| 711635 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Profile of Ipragliflozin, an Oral SGLT-2 Inhibitor for the Treatment of Type 2 Diabetes: The Evidence to Date |
2021-07-01 |
10.2147/dddt.s281602 |
Alkabbani Wajd, Gamble John-Michael |
| 711634 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Review of Allopregnanolone Agonist Therapy for the Treatment of Depressive Disorders |
2021-07-01 |
10.2147/dddt.s240856 |
Walkerly Autumn, Leader Lauren D, Cooke Emily, VandenBerg Amy |
| 711633 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Superhydrophobic Surface for Enhancing the Bioavailability of Salbutamol Sulfate from Cross-Linked Microspheres: Formulation, Characterization, and in vivo Evaluation |
2021-07-01 |
10.2147/dddt.s309078 |
Gaber Dalia, Abdoun Siham, Alfuraihy Ameerah, Altasan Bushra, Alsubaiyel Amal |
| 711632 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Pharmacokinetic Study of Frovatriptan Succinate Tablet After Single and Multiple Oral Doses in Chinese Healthy Subjects |
2021-07-01 |
10.2147/dddt.s308958 |
Zheng Hongquan, Xia Yan, Qu Shengjun, Fan Lin, Zhang Jingjing, Ma Zhixiang, Chen Yangsheng, Fan Hongwei |
| 711631 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TPN171H, a Novel Phosphodiesterase Type 5 Inhibitor, in Healthy Subjects |
2021-07-01 |
10.2147/dddt.s308610 |
Qian Hongjie, Chen Qian, Liang Liyu, Zou Yang, Pu Huahua, Xin Liang, Song Rong, Li Tingting, Zhu Huijuan, Wang Yu, Tian Guanghui, Shen Jingshan, Jiang Hualiang, Yu Chen, Wang Zhen, Jia Jingying |
| 711630 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Hepatoprotective Effects of Polysaccharide from Anoectochilus roxburghii (Wall.) Lindl. on Rat Liver Injury Induced by CCl4 |
2021-07-01 |
10.2147/dddt.s310263 |
Yu Xiaoling, Huang Lingyi, You Chen, Huang Liying |
| 711629 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
The Development of Disease-Modifying Therapies for Osteoarthritis (DMOADs): The Evidence to Date |
2021-07-01 |
10.2147/dddt.s295224 |
Oo Win Min, Little Christopher, Duong Vicky, Hunter David J |
